SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EYES Second Sight-Eyeglasses for the Blind help them see
EYES 4.140-5.0%Aug 30 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Julius Wong11/2/2017 9:56:43 PM
   of 99
 
Second Sight on go to start study of Orion Cortical Visual Prosthesis
  • The FDA has signed off on a clinical feasibility study evaluating Second Sight Medical's (NASDAQ: EYES) Orion Cortical Visual Prosthesis System. The approval allows two U.S. sites, UCLA and Baylor, to enroll up a total of five patients.
  • Orion is designed to stimulate the brain's visual cortex in order to produce the perception of patterns of light in completely blind people. Like the Argus II, images captured by a small camera mounted on the person's glasses are wirelessly transmitted to an array of electrodes (in this case on the visual cortex instead of the retina) which produces the perception of patterns of light.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext